CVXL-0107
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CVXL-0107, covering 2017-07-24 to 2017-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease [Phase 2]